About iSirona
iSirona is a company based in El Segundo (United States) founded in 2007 by Joe Kiani was acquired by NantHealth in January 2013.. iSirona has raised $1.5 million across 2 funding rounds from investors including NantHealth and Abraxis BioScience. The company has 1,317 employees as of December 31, 2021. iSirona offers products and services including Iris Gateway, Pulse Oximetry, and Root. iSirona operates in a competitive market with competitors including Tyto Care, Edwards Lifesciences, BioIntelliSense, Endotronix and Athelas, among others.
- Headquarter El Segundo, United States
- Employees 1317 as on 31 Dec, 2021
- Founders Joe Kiani
-
Sectors
HealthcareTechnology
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.5 M (USD)
in 2 rounds
-
Latest Funding Round
$1.5 M (USD), Seed
Oct 27, 2009
-
Investors
NantHealth
& 1 more
-
Employee Count
1317
as on Dec 31, 2021
-
Acquired by
NantHealth
(Jan 01, 2013)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of iSirona
iSirona offers a comprehensive portfolio of products and services, including Iris Gateway, Pulse Oximetry, and Root. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Facilitates data transfer from medical devices to electronic records
Measures blood oxygen levels for patient vital signs
Integrates various monitoring technologies for hospital use
Funding Insights of iSirona
iSirona has successfully raised a total of $1.5M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.5 million completed in October 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $1.5M
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2009 | Amount | Seed - iSirona | Valuation |
investors |
|
| Jun, 2008 | Amount | Seed - iSirona | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in iSirona
iSirona has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include NantHealth and Abraxis BioScience. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Protein-based nanoparticle chemotherapeutics for cancer are developed.
|
Founded Year | Domain | Location | |
|
Bioinformatics platforms are provided for cancer treatment identification.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by iSirona
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - iSirona
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Isirona Comparisons
Competitors of iSirona
iSirona operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tyto Care, Edwards Lifesciences, BioIntelliSense, Endotronix and Athelas, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Medical consultations are facilitated via self-exams and remote diagnostic devices.
|
|
| domain | founded_year | HQ Location |
Medical devices for structural heart disease are developed and provided.
|
|
| domain | founded_year | HQ Location |
Vital signs are monitored via a single-use patch and platform.
|
|
| domain | founded_year | HQ Location |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring.
|
|
| domain | founded_year | HQ Location |
Provider of smart solutions for monitoring heart rate, weight, and blood pressure
|
|
| domain | founded_year | HQ Location |
Remote monitoring platform for tracking patient activity
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about iSirona
When was iSirona founded?
iSirona was founded in 2007 and raised its 1st funding round 1 year after it was founded.
Where is iSirona located?
iSirona is headquartered in El Segundo, United States. It is registered at El Segundo, California, United States.
Who is the current CEO of iSirona?
Joe Kiani is the current CEO of iSirona. They have also founded this company.
Is iSirona a funded company?
iSirona is a funded company, having raised a total of $1.5M across 2 funding rounds to date.
How many employees does iSirona have?
As of Dec 31, 2021, the latest employee count at iSirona is 1,317.
What does iSirona do?
Digital patient monitoring tool for providers. The companys innovative noninvasive patient monitoring technologies, hospital automation systems, home monitoring devices, ventilation solutions, and consumer items are all developed and produced by a medical technology business. It provides home health management tools including continuous thermometers that are of hospital-grade quality. Additionally, the business offers Masimo SafetyNet, a monitoring system for young patients.
Who are the top competitors of iSirona?
iSirona's top competitors include Tyto Care, Endotronix and Athelas.
What products or services does iSirona offer?
iSirona offers Iris Gateway, Pulse Oximetry, and Root.
Who are iSirona's investors?
iSirona has 2 investors. Key investors include NantHealth, and Abraxis BioScience.